Masaru Matsuda

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
San Diego, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Latha Vairavan, as Attorney-in-Fact for Masaru Matsuda
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Masaru Matsuda

Form 4 holding SVP, General Counsel

HALOZYME THERAPEUTICS, INC.

Security class
Common Stock
Shares / value
20,049
Estimated value
$721,764
Report date
04 Sep 2021
Price
$36.00
Ownership
Direct
Form 4 holding SVP, General Counsel

HALOZYME THERAPEUTICS, INC.

Security class
Restricted Stock Units
Shares / value
6,883
Estimated value
$278,032
Report date
04 Sep 2021
Price
$40.39
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Reporting Person's title: EVP, Chief Legal Officer

Arcutis Biotherapeutics, Inc.

Security class
Stock Option (right to buy)
Shares / value
97,000
Estimated value
Report date
27 Feb 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Masaru Matsuda

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .